Keyphrases
EcoHIV
58%
Human Immunodeficiency Virus Type 1 (HIV-1)
42%
Cognitive Impairment
32%
HIV-associated Neurocognitive Disorders
30%
Neurocognitive Disorders
25%
Brain Tissue
21%
Antiretroviral Therapy
20%
Infected Mice
19%
Opioid Response
16%
AIDS/HIV
16%
Astrocytes
16%
Innate Immune Response
16%
Macrophages
15%
Neuropathogenesis
12%
Conventional Mouse
11%
Viral
11%
Substance Use Disorder
11%
HIV-1 Replication
11%
HIV Neuropathogenesis
10%
Alzheimer's Disease
10%
Mouse Brain
10%
Type I Interferon
10%
Virus
9%
Primary Astrocytes
9%
Neurocognitive Impairment
9%
Gene Expression Profile
9%
NF-B
9%
Infectious Diseases
8%
Glia
8%
RNA Sequencing (RNA-seq)
8%
Adipose Cells
8%
Interleukin-6
8%
Synaptodendritic Injury
8%
Complement C3
8%
Dendritic Injury
8%
Prevention of HIV Infection
8%
Multiple Sclerosis
8%
Brain Cell Cultures
8%
In Vitro Infection
8%
Latent Viral Reservoir
8%
Treatment of HIV Infection
8%
Transcriptional Signature
8%
Drug Efficacy
8%
Ceftriaxone
8%
Extracellular Vesicles
8%
T Cells
8%
Vesicle Release
8%
Viral Reservoir
8%
Neurobehavioral Deficits
8%
Glutamate Uptake
8%
Neuroscience
Human Immunodeficiency Virus
100%
Astrocyte
25%
HIV Associated Dementia
19%
Gene Expression
18%
Cognitive Disorders
17%
Alzheimer's Disease
10%
Interferon
10%
Substance Abuse
10%
Polycytidylic Acid
9%
Microglia
9%
Insulin Therapy
8%
Glia
8%
Interleukin 6
8%
Cell Culture
8%
Multiple Sclerosis
8%
Complement Component C3
8%
Memory Disorder
8%
Ceftriaxone
8%
Excitatory Amino Acid Transporter 2
8%
Sphingomyelin Phosphodiesterase
8%
Glutamic Acid
8%
Major Depressive Disorder
6%
Promoter Region
6%
Real-Time Polymerase Chain Reaction
6%
Macrophage
5%
